Inmedix

Normandy Park, WA · Founded 2017 · Privately Held (backing)

Developer of a medical technology designed to assess autonomic nervous system function with clinical precision. Inmedix is based in Normandy Park, WA and was founded in 2017. It was valued at $33.5 million at its later-stage round in Nov 2024, the last priced event on record. It has raised $16.3 million across 3 recorded rounds; the latest was a $720,000 seed round in Aug 2024.

PMV mark · valuation
$33.5M
Oct 2026
Priced at
its later-stage round
Nov 2024
Total raised
$16.3M
Last round
Seed Round
Aug 2024

Who backs Inmedix?

8 investors
InvestorType
Keiretsu ForumOther
Cairi Legacy PartnersFamily office
Andrew Holman—
Keiretsu Capital—
NW Angel—
Pacific Rheumatology Research—
Puget Sound Venture Club—
Stuart Hwang—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Inmedix investors

8 investors are on record for Inmedix, including Keiretsu Forum, Cairi Legacy Partners, Andrew Holman and Keiretsu Capital. The seed round in Aug 2024 drew 5 investors.

Free account
More of Inmedix with a free account
  • ·Watch Inmedix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Inmedix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View